2010 30 5 975 -β1shrna 215123 TGF -β1 RNA shrna TGF-β1 mrna Ambion Target Finder TGF-β1shRNA BglⅡ HindⅢ psuper gfp-neo shrna psuper gfp-neo DH5a ELISA TGF-β1shRNA ELISA shrna-a shrna-b shrna-c TGF-β1 shrna-b P < 0. 05 TGF-β1shRNA TGF-β1 RNA -β1 R730. 3 A 1673-0399 2010 05-0975 - 03 Construction and Identification of Transforming Growth Factor-β1 shrna Expressing Vector ZHANG Biao GUO Ling-chuan DONG Liang ZHOU Yun WU Chun HU Xin PAN Zhan-teng ZHONG Liang-jun WANG Shou-li Dept of Pathology Medical College Soochow University Jiangsu Suzhou 215123 China Abstract Objective To construct transforming growth factor-β1 TGF-β1 short hairpin RNA shrna -expressing vector and provide the basis for further experiments in cancer biology. Methods TGF-β1-specific shrnas were designed with the Target Finder of Ambion according to mrna of TGFβ1 and were ligated into the mammalian expression vector psuper gfp-neo at the BglII and HindIII cloning sit. The recombinant shrnapsuper gfp-neo was used to transform Escherichia coli DH5a which was selected and verified by sequencing. Then select the optimal site for TGFB1 gene silencing with enzyme-linked immunosorbent assay ELISA and Immunofluorescence. Results ELISA and immunofluorescence staining showed reduced expression of TGF-b1 protein in RD cells transfected with shrna-a shrna-b and shrna-c. The reduction was most pronounced P < 0. 05 in cells transfected with shr- NA-b. Conclusion These data suggest that the constructed TGF-β1shRNA-expressing vector produces efficient TGF-β1 knockdown in the tumor cell line and may be a method of cancer biological research. Key words RNA interference transforming growth factor-β1 expressing vector construction 81072186 5731512810 KY2010343B 2009-11 - 09 1989 -
976 SUZHOU UVIVERSITY JOURNAL OF MEDICAL SCIENCE 2010 30 5 transforming growth factor TGF-β1 Santa Cruz TGF -β1 1 100 FITC - IgG 1 1 h RNA RNA interference RNAi 3 1. 4 ELISA RD 4 10 4 / 96 RNA 1 2 4 d 6 d ELISA TGF-β1 96 RD TGF-β1 HRP TGFβ1 A TβR Smad TGFβ1 2 shrna 1. 5 SPSS 10. 0 χ 2 TGF-β1 t P < 0. 05 1 2 1. 1 shrna 2. 1 TGF-β1-shRNA psuper OligoEngine H1RNA Ⅲ psuper BglⅡ HindⅢ H1RNA RNA 19bp shrna RNA Ambion Target Finder TGF-β1shRNA 9-nt 1 19nt 19nt BLAST 3 Target Finder BglⅡ HindⅢ shrna psuper DH5a TGF-β1 shrna 1. 2 DMEM Lipofectamine TM 2 000 TGF-β1shRNA 1 1 Lip- shrna RD 1 10 5 /ml 6 24 h DMEM 2 ml 250 μl 1 TGF-β1shRNA RD TGF-β1 TGF-β1shRNA 1. 3 2. 2 TGF-β1shRNA TGF-β1 4 4% 15 min PBS 37 2 TGFβ1shRNA 1 5% 30 min 4 1 shrna
2010 30 5 977 TGF-β1 TGF-β1shRNA-b sirna TGF-β1 sirna P < 0. 05 1 1 TGF-β1shRNA RD H1 RNA RD TGF-β1 % sirna TGF-β1shRNA-un 82 53. 654 ± 4. 573 TGF-β1shRNA-a 77 52. 542 ± 3. 854 * TGF-β1shRNA-b 27 * 18. 275 ± 2. 2 * TGF-β1shRNA-c 68 47. 542 ± 3. 854 * * P < 0. 05 2. 3 TGF-β1shRNA TGF-β1 6 RNA 7 ELISA 3 shrna-a shrnab shrna-c RD TGF-β1 -sirna shrna-b P < 0. 05 TGF-β1 shrna ELISA TGF-β1shRNA TGF- 3 3 ELISA TGF-β1shRNA TGF-β1 sirna 5 psuper psuper BglⅡ HindⅢ RNA 19nt 9-nt H1RNA shrna β1shrna TGF-β1 TGF-β1shRNA-b ELISA TGF-β1 shrna-b P < 0. 05 TGF-β1-shRNA TGF-β1 1 393 ~ 11 413 shrna-b RNAi RNAi shrna TGF-β1 8 RNAi 3 TGF-β1 4 dsr- NA sirna RNAi 1001
2010 30 5 1001 RSV 75 8. 73% ADV 145 ADV 5 Carballal G Videla C Misirlian A et al. Adenovirus type MP 47 32. 41% 7 associated with severe and fatal acute lower respiratory 145 infection in Argentine children J. BMC Pediatr 2002 16 ADV 2 6. hmpv 6 6 Chen HL Chiou SS Hsiao HP et al. Respiratory adenoviral infections in children a study of hospitalized cses in 4. 14% 8 hmpv ADV southern Taiwan in 2001-2002 J. J Trop Pediat 2004 50 5 279-284. ADV 7. MP J. 3 2005 5 3 152-154. P 0. 05 3 P 2. 2000 2002 0. 01 J. 2003 21 1 25-28. P 0. 05 3. 8 ADV IVA PIV1 ~ 3 J. 2 ADV IVB 1 2007 28 7 686-687. ADV RSV 8 4 Barraza EM Ludwig SL Gaydos JC et al. Reemergence 1 125 IV of adenovirus type 4 acute respiratory disease in military RSV 211 18. 76% 859 PIV trainees report of an outbreak during a lapse in vaccination J. J Infect Dis 1999 179 6 1531-1533. 2006 24 3 194-196. 8. 1. J. J. 2007 45 1 42-45. 檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷檷 977 1 Roberts AB Wakefield LM. The two faces of transforming growth factor beta in carcinogenesis J. Proc Natl Acad Sci USA 2003 100 15 8621-8623. 2 Wang H Yang YG Bu H et al. Systematic analysis of the TGF-b / Smad signaling pathway in the rhabdomyosarcoma cell line RD J. Int J Exp Path 2003 84 2 153-163. 3 Stover DG Bierie B Moses HL. A delicate balance TGFbeta and the tumor microenvironment J. J Cell Biochem 2007 101 4 851-861. 4 Biswas S Criswell TL Wang SE et al. Inhibition of transforming growth factor-beta signaling in human cancer targeting a tumor suppressor network as a therapeutic strategy J. Clin Cancer Res 2006 12 14 4142-4146. 5 Brummelkamp TR Bernards R Agami R. A system for stable expression of short interfering RNAs in mammalian cells J. Science 2002 296 5567 550-553. 6 Barreau C Dutertre S Paillard L et al. Liposome-mediated RNA transfection should be used with caution J. RNA 2006 12 10 1790-1793. 7. TGF-β1 shr- NA J. 2008 28 2 222-225. 8 Grimm D Streetz KL Jopling CL et al. Fatality in mice due to oversaturation of cellular microrna / short hairpin RNA pathways J. Nature 2006 441 7092 537-541.